Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

FOLD

Amicus Therapeutics Inc

Feb 13 • 04:00PM ET

14.31

-0.02 -0.14 %

Healthcare • Biotechnology • USA • NASD

Peers: VRTX SRPT BMRN REGN CRSP EDIT PFE QURE AGIO BLUE

| Held by: VTI XBI IWM VB VBK VXF IWO IBB SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-0.04	Insider Own	1.74%	Shs Outstand	308.50M	Perf Week	0.07%
Market Cap	4.49B	Forward P/E	50.09	EPS next Y	0.29	Insider Trans	-7.71%	Shs Float	308.45M	Perf Month	-0.49%
Enterprise Value	4.67B	PEG	-	EPS next Q	0.07	Inst Own	91.72%	Short Float	5.82%	Perf Quarter	51.91%
Income	-14.06M	P/S	7.50	EPS this Y	92.06%	Inst Trans	-3.29%	Short Ratio	1.64	Perf Half Y	100.98%
Sales	598.70M	P/B	19.16	EPS next Y	2099.96%	ROA	-1.70%	Short Interest	17.96M	Perf YTD	0.49%
Book/sh	0.75	P/C	17.03	EPS next 5Y	-	ROE	-6.87%	52W High	14.38 -0.49%	Perf Year	48.44%
Cash/sh	0.84	P/FCF	463.59	EPS past 3/5Y	41.55% 34.10%	ROIC	-2.12%	52W Low	5.51 159.71%	Perf 3Y	13.21%
Dividend Est.	-	EV/EBITDA	110.90	Sales past 3/5Y	20.03% 23.72%	Gross Margin	88.50%	Volatility	0.29% 0.24%	Perf 5Y	13.84%
Dividend TTM	-	EV/Sales	7.80	EPS Y/Y TTM	87.30%	Oper. Margin	5.77%	ATR (14)	0.08	Perf 10Y	168.48%
Dividend Ex-Date	-	Quick Ratio	2.09	Sales Y/Y TTM	21.28%	Profit Margin	-2.35%	RSI (14)	77.45	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.99	EPS Q/Q	352.49%	SMA20	0.10%	Beta	0.43	Target Price	14.50
Payout	-	Debt/Eq	1.92	Sales Q/Q	19.46%	SMA50	7.44%	Rel Volume	0.64	Prev Close	14.33
Employees	499	LT Debt/Eq	1.88	Earnings	Nov 04 BMO	SMA200	61.63%	Avg Volume	10.96M	Price	14.31
IPO	May 31, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	55.44% 2.02%	Trades		Volume	7,000,580	Change	-0.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-22-26	Downgrade	Jefferies	Buy → Hold	$14.50
Dec-29-25	Downgrade	Leerink Partners	Outperform → Market Perform	$14.50
Dec-22-25	Downgrade	TD Cowen	Buy → Hold	$14.50
Dec-17-25	Initiated	Citigroup	Buy	$17
Sep-18-25	Upgrade	Needham	Hold → Buy	$14
Jul-17-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$108
Dec-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $12
Sep-06-24	Initiated	Jefferies	Buy	$18
May-30-24	Initiated	Wells Fargo	Overweight	$18
May-14-24	Upgrade	Guggenheim	Neutral → Buy	$13
Dec-19-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$15 → $20
Sep-09-22	Initiated	Morgan Stanley	Equal-Weight	$14
Apr-13-22	Resumed	Goldman	Neutral	$11
Jan-14-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$12 → $16
Nov-15-21	Upgrade	Stifel	Hold → Buy	$12 → $16
Sep-30-21	Upgrade	JP Morgan	Neutral → Overweight	$16
Jul-19-21	Resumed	BTIG Research	Buy	$15
May-27-21	Initiated	Needham	Hold
May-21-21	Initiated	UBS	Buy	$16
Apr-14-21	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$17

Show Previous Ratings

Feb-11-26 08:30AM	Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings? (Zacks)
Feb-03-26 08:00AM	Amicus Therapeutics Presents New Long-term Data for both Galafold (migalastat) and POMBILITI (cipaglucosidase alfa-atga) + OPFOLDA (miglustat) at the 22nd Annual WORLDSymposium 2026 (GlobeNewswire)
Feb-02-26 09:29AM	Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments (Insider Monkey)
Jan-28-26 11:24AM	FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside? (Zacks)
Jan-23-26 07:18AM	JANX Enters Global Oncology Collaboration With BMY, Stock Rises (Zacks)
11:55AM	Loading…
Jan-22-26 11:55AM	Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema (Zacks)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More (24/7 Wall St.)
Jan-21-26 10:46AM	ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission (Zacks)
10:12AM	NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies (Zacks)
08:36AM	MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know (Zacks)
Jan-19-26 12:53PM	Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease (Zacks)
08:01AM	Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus (Zacks)
Jan-16-26 11:15AM	Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia (Zacks)
11:01AM	FOLD Rises 136% in 6 Months: Should You Buy, Sell or Hold the Stock? (Zacks)
09:06AM	Erasca Stock Surges 42% in a Week: Here's What You Should Know (Zacks)
11:16AM	Loading…
Jan-15-26 11:16AM	Apellis Stock Crashes 23% in a Week: Here's What You Should Know (Zacks)
10:26AM	CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why (Zacks)
06:47AM	One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit (24/7 Wall St.)
Jan-14-26 10:52AM	TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results (Zacks)
10:18AM	PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific (Zacks)
Jan-13-26 01:28PM	ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook (Zacks)
09:19AM	Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes (Zacks)
Jan-12-26 02:07PM	KRYS Reports Preliminary Results for 2025, Outlines 2026 Objectives (Zacks)
11:20AM	MDGL Secures Exclusive Global Right for MASH Treatment From PFE (Zacks)
10:14AM	PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates (Zacks)
09:33AM	Exelixis Posts Preliminary '25 Results, Issues '26 Outlook (Zacks)
Jan-09-26 11:46AM	AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations (Zacks)
09:17AM	Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress (Zacks)
Jan-08-26 12:49PM	Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:09AM	GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug (Zacks)
09:44AM	Loading…
09:44AM	KRYS Stock Surges 57% in a Year: More Upside Potential in 2026? (Zacks)
08:50AM	EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study (Zacks)
Jan-07-26 09:53AM	OTLK Stock Crashes 67% in a Week: Here's What You Need to Know (Zacks)
Jan-06-26 11:47AM	Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase? (Zacks)
11:15AM	Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings? (Zacks)
10:50AM	Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Jan-02-26 01:13PM	When healthcare M&A hits the cold chain (FreightWaves)
Dec-30-25 10:19AM	Halper Sadeh LLC Encourages EKSO, FOLD, WBD, CFLT Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-29-25 07:52AM	Here Are Mondays Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More (24/7 Wall St.)
Dec-23-25 06:45PM	Halper Sadeh LLC Encourages KPLT, FOLD, DHIL Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-22-25 12:27PM	BioMarin snaps up Amicus Therapeutics for $4.8bn amid rare disease push (Pharmaceutical Technology)
12:15PM	A $4.8 Billion Reason to Buy BioMarin Stock Today (Barchart)
11:46AM	BioMarin to Buy Rare Disease Drugmaker Amicus Therapeutics for $4.8B (Zacks)
09:47AM	Arcellx initiated, Cummins upgraded: Wall Street's top analyst calls (The Fly)
09:29AM	Cytokinetics Wins FDA Approval for Cardiovascular Drug, Stock up (Zacks)
Dec-20-25 08:12AM	Amicus (FOLD) Flies to 52-Week High on $5-Billion BioMarin Merger (Insider Monkey)
Dec-19-25 04:32PM	Stocks to Watch Friday Recap: Lamb Weston, Intuitive Machines, Nike, Oracle (The Wall Street Journal) +30.21%
04:17PM	BioMarin Soars 18% After Folding In The $4.8 Billion Takeover Of Amicus (Investor's Business Daily)
12:41PM	Biotech Bombshell: BioMarin's $4.8B Bet Ignites Amicus Shares in Rare-Disease Power Play (GuruFocus.com)
12:17PM	Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates (Zacks)
11:57AM	BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion (The Wall Street Journal)
11:01AM	Stocks to Watch Friday: Lamb Weston, Intuitive Machines, Nike, Oracle (The Wall Street Journal)
10:55AM	BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. (Barrons.com)
09:38AM	Stocks to Watch Friday: Nike, Oracle, FedEx, Sony (The Wall Street Journal)
09:33AM	BioMarin Pharmaceutical Scoops Up Amicus Therapeutics In $4.8 Billion Deal (Investor's Business Daily)
08:13AM	BioMarin to Buy Amicus Therapeutics for $4.8 Billion (The Wall Street Journal)
07:45AM	BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook (PR Newswire)
Dec-18-25 03:43AM	Zacks Industry Outlook Arcutis, Amicus and ANI (Zacks)
Dec-17-25 02:19PM	5 Biotech Stocks to Watch for Potential Upside (Zacks)
Dec-16-25 10:30AM	FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? (Zacks)
08:53AM	GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal (Zacks)
Dec-15-25 09:59AM	RCUS Stock Down on Decision to Discontinue GILD Partnered Study (Zacks)
Dec-13-25 07:05AM	Amicus Therapeutics (FOLD) Soars to 52-Week High on 'Strong Buy' Reco (Insider Monkey)
Dec-12-25 09:55AM	Wall Street Analysts See a 60.61% Upside in Amicus Therapeutics (FOLD): Can the Stock Really Move This High? (Zacks) +6.57%
Dec-09-25 01:48PM	The Best Cheap Stocks Under $10 to Buy in December and 2026 (Zacks)
Dec-08-25 08:23AM	Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus (Zacks)
Dec-05-25 12:20PM	Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock (Zacks)
09:57AM	Can Galafold Continue to Drive Amicus' Top Line in 2026? (Zacks)
Dec-04-25 11:30AM	Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
10:29AM	BMY Gains on News of Continuation of Alzheimer's Disease Study (Zacks)
Dec-02-25 02:20PM	BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business (Zacks)
Nov-26-25 09:55AM	Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet (Zacks)
Nov-25-25 02:00PM	FDA Greenlights Novartis' Gene Replacement Treatment for SMA (Zacks)
Nov-24-25 01:53PM	BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study (Zacks)
Nov-21-25 10:15AM	NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth (Zacks)
Nov-19-25 08:53AM	BAYRY Obtains Approval for Hormone Free VMS Treatment Lynkuet in the EU (Zacks)
Nov-14-25 08:11AM	GILD's Investigational Regimen for HIV Treatment Meets Primary Goal (Zacks)
Nov-13-25 01:46PM	Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth? (Zacks)
Nov-11-25 12:52PM	Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus (Zacks)
Nov-10-25 08:16PM	Goldman Sachs Bullish on Amicus Therapeutics (FOLD) Following Q3 2025 Results (Insider Monkey)
09:55AM	Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to Trade (Zacks)
01:44AM	Zacks.com featured highlights include EverQuote, Amicus, Lam Research and Cboe Global Markets EverQuote, Amicus, Lam Research and Cboe Global Markets (Zacks)
Nov-07-25 10:40AM	Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns (Zacks)
Nov-06-25 10:43AM	Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y (Zacks)
10:24AM	Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance (Zacks)
09:24AM	RXRX Q3 Loss Narrower Than Expected, Revenues Decline Y/Y (Zacks)
08:27AM	ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales (Zacks)
Nov-05-25 10:52AM	EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales (Zacks)
10:48AM	Ultragenyx Q3 Earnings and Sales Miss Estimates, Increase Y/Y (Zacks)
10:41AM	Madrigal Q3 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Up (Zacks)
10:30AM	Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles (Zacks)
10:08AM	Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues (Zacks)
09:30AM	Compared to Estimates, Amicus Therapeutics (FOLD) Q3 Earnings: A Look at Key Metrics (Zacks)
Nov-04-25 04:07PM	Amicus Therapeutics Inc (FOLD) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
11:43AM	ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down (Zacks)
09:54AM	Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
08:35AM	Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:29AM	Amicus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates (GlobeNewswire)
Oct-31-25 01:45PM	Apellis Stock Down Despite Q3 Earnings and Revenues Beat Estimates (Zacks)

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Campbell Bradley L	President and CEO	Jan 20 '26	Option Exercise	6.10	75,000	457,500	1,096,180	Jan 22 07:26 PM
Campbell Bradley L	President and CEO	Jan 20 '26	Sale	14.31	75,000	1,073,182	1,021,180	Jan 22 07:26 PM
BRADLEY CAMPBELL	Director	Jan 20 '26	Proposed Sale	14.33	75,000	1,074,750		Jan 20 04:26 PM
Clark David Michael	Chief People Officer	Dec 19 '25	Sale	14.17	25,642	363,380	245,690	Dec 23 04:16 PM
DAVID CLARK	Officer	Dec 19 '25	Proposed Sale	10.89	25,642	279,241		Dec 19 04:22 PM
Campbell Bradley L	President and CEO	Dec 15 '25	Option Exercise	9.03	70,426	635,947	1,207,708	Dec 17 06:21 PM
Campbell Bradley L	President and CEO	Dec 15 '25	Sale	10.86	77,926	846,011	1,129,782	Dec 17 06:21 PM
Clark David Michael	Chief People Officer	Dec 15 '25	Sale	11.00	25,643	282,073	271,332	Dec 17 06:19 PM
BRADLEY CAMPBELL	Director	Dec 15 '25	Proposed Sale	10.55	77,926	822,119		Dec 15 04:32 PM
DAVID CLARK	Officer	Dec 15 '25	Proposed Sale	10.55	25,643	270,534		Dec 15 04:17 PM
Campbell Bradley L	President and CEO	Dec 01 '25	Option Exercise	9.03	14,587	131,721	1,151,869	Dec 03 08:11 PM
Campbell Bradley L	President and CEO	Dec 01 '25	Sale	10.01	14,587	146,011	1,137,282	Dec 03 08:11 PM
BRADLEY CAMPBELL	Director	Dec 01 '25	Proposed Sale	9.93	14,587	144,849		Dec 01 04:19 PM
Castelli Jeff	Chief Development Officer	Nov 24 '25	Option Exercise	9.03	50,000	451,500	515,476	Nov 26 09:18 PM
Castelli Jeff	Chief Development Officer	Nov 24 '25	Sale	10.16	76,158	773,659	439,318	Nov 26 09:18 PM
Clark David Michael	Chief People Officer	Nov 24 '25	Sale	10.10	25,643	258,933	296,975	Nov 26 09:17 PM
Campbell Bradley L	President and CEO	Nov 24 '25	Option Exercise	9.03	14,587	131,721	1,151,869	Nov 26 09:17 PM
Campbell Bradley L	President and CEO	Nov 24 '25	Sale	10.04	14,587	146,522	1,137,282	Nov 26 09:17 PM
Rosenberg Ellen	Chief Legal Officer	Nov 24 '25	Option Exercise	5.80	36,000	208,930	543,710	Nov 26 09:16 PM
Rosenberg Ellen	Chief Legal Officer	Nov 25 '25	Option Exercise	5.13	36,000	184,680	543,710	Nov 26 09:16 PM
Rosenberg Ellen	Chief Legal Officer	Nov 26 '25	Option Exercise	5.13	23,621	121,176	531,331	Nov 26 09:16 PM
Rosenberg Ellen	Chief Legal Officer	Nov 24 '25	Sale	10.06	36,000	362,268	507,710	Nov 26 09:16 PM
Rosenberg Ellen	Chief Legal Officer	Nov 25 '25	Sale	10.00	36,000	360,000	507,710	Nov 26 09:16 PM
Rosenberg Ellen	Chief Legal Officer	Nov 26 '25	Sale	10.00	23,621	236,210	507,710	Nov 26 09:16 PM
ELLEN ROSENBERG	Officer	Nov 26 '25	Proposed Sale	9.87	23,621	233,139		Nov 26 04:18 PM
ELLEN ROSENBERG	Officer	Nov 25 '25	Proposed Sale	9.89	36,000	356,040		Nov 25 04:27 PM
JEFFREY CASTELLI	Officer	Nov 24 '25	Proposed Sale	9.56	76,158	728,070		Nov 24 04:25 PM
DAVID CLARK	Officer	Nov 24 '25	Proposed Sale	9.56	25,643	245,147		Nov 24 04:24 PM
BRADLEY CAMPBELL	Director	Nov 24 '25	Proposed Sale	9.56	14,587	139,452		Nov 24 04:24 PM
ELLEN ROSENBERG	Officer	Nov 24 '25	Proposed Sale	9.56	36,000	344,160		Nov 24 04:23 PM
Clark David Michael	Chief People Officer	Nov 04 '25	Sale	9.51	25,643	243,860	322,618	Nov 05 04:05 PM
DAVID CLARK	Officer	Nov 04 '25	Proposed Sale	8.86	25,643	227,197		Nov 04 04:33 PM
Campbell Bradley L	President and CEO	Feb 19 '25	Option Exercise	9.03	400	3,612	1,151,057	Feb 21 07:27 PM
Campbell Bradley L	President and CEO	Feb 19 '25	Sale	10.00	400	4,000	1,150,657	Feb 21 07:27 PM
BRADLEY CAMPBELL	Director	Feb 19 '25	Proposed Sale	9.85	400	3,940		Feb 19 04:36 PM

Open in Screener

SCOR

Comscore Inc

Feb 13 • 04:00PM ET

7.50

+0.44 6.23 %

Technology • Software - Application • USA • NASD

Peers: FLNT PERI TTD MGNI ACIW APPS PUBM FUBO EVLV ROKU

| Held by: VTI VXF ONEQ BSVO DCOR

Index	-	P/E	-	EPS (ttm)	-5.53	Insider Own	0.00%	Shs Outstand	5.02M	Perf Week	0.13%
Market Cap	37.62M	Forward P/E	1.61	EPS next Y	4.65	Insider Trans	-	Shs Float	5.02M	Perf Month	-12.68%
Enterprise Value	273.72M	PEG	-	EPS next Q	1.94	Inst Own	21.45%	Short Float	0.14%	Perf Quarter	12.44%
Income	-28.33M	P/S	0.10	EPS this Y	262.14%	Inst Trans	1.77%	Short Ratio	0.34	Perf Half Y	16.28%
Sales	358.94M	P/B	-	EPS next Y	109.46%	ROA	-2.41%	Short Interest	0.01M	Perf YTD	15.38%
Book/sh	-5.24	P/C	1.26	EPS next 5Y	-	ROE	-5.12%	52W High	10.18 -26.31%	Perf Year	3.59%
Cash/sh	5.96	P/FCF	-	EPS past 3/5Y	-0.04% 31.98%	ROIC	-12.35%	52W Low	4.39 70.84%	Perf 3Y	-68.75%
Dividend Est.	-	EV/EBITDA	8.61	Sales past 3/5Y	-1.01% -1.74%	Gross Margin	38.69%	Volatility	11.35% 8.70%	Perf 5Y	-90.51%
Dividend TTM	-	EV/Sales	0.76	EPS Y/Y TTM	74.60%	Oper. Margin	0.53%	ATR (14)	0.70	Perf 10Y	-98.95%
Dividend Ex-Date	-	Quick Ratio	0.65	Sales Y/Y TTM	0.77%	Profit Margin	-7.89%	RSI (14)	45.49	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.65	EPS Q/Q	93.27%	SMA20	-8.15%	Beta	1.14	Target Price	10.00
Payout	-	Debt/Eq	0.32	Sales Q/Q	0.48%	SMA50	-0.54%	Rel Volume	0.53	Prev Close	7.06
Employees	1200	LT Debt/Eq	0.27	Earnings	Nov 04 AMC	SMA200	15.95%	Avg Volume	20.97K	Price	7.50
IPO	Jun 27, 2007	Option/Short	No / Yes	EPS/Sales Surpr.	-172.97% 0.31%	Trades		Volume	11,140	Change	6.23%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-29-24	Downgrade	Craig Hallum	Buy → Hold	$18 → $8
Aug-10-21	Reiterated	Needham	Buy	$6 → $4.50
Jun-28-21	Initiated	Craig Hallum	Buy	$7
Jan-11-21	Upgrade	Loop Capital	Hold → Buy	$3 → $4
Feb-28-20	Reiterated	Aegis Capital	Buy	$7 → $8
May-10-19	Reiterated	Needham	Buy	$28 → $15
Apr-02-19	Reiterated	Aegis Capital	Buy	$30 → $25
Apr-01-19	Downgrade	SunTrust	Buy → Hold
Apr-01-19	Downgrade	Loop Capital	Buy → Hold
Mar-04-19	Resumed	SunTrust	Buy	$27
Mar-01-19	Reiterated	Needham	Buy	$20 → $28
Nov-29-18	Initiated	Needham	Buy	$20
Oct-11-18	Initiated	Aegis Capital	Buy	$29
Jun-12-18	Initiated	Loop Capital	Buy	$32

Show Previous Ratings

Jan-29-26 09:00AM	AI Assistants Head into 2026 on a High Note: Comscore Reports Triple-Digit Growth on Mobile (GlobeNewswire)
Jan-20-26 06:08PM	Netflix Should Adopt Warner's Theater Strategy: Comscore (Bloomberg)
09:00AM	Comscore 2026 State of Programmatic Report: CTV and Audio expected to drive growth with cross-channel performance measurement critical to smarter allocation across platforms (GlobeNewswire)
Jan-08-26 09:00AM	Comscore Launches Audio Targeting and Measurement Capabilities with The Trade Desk, Helping to Unlock Incremental Reach for Advertisers (GlobeNewswire) +11.80%
Jan-07-26 08:00AM	Comscore's Cross-Platform Content Measurement to Service ESPN, Strengthening Audience Insights and Better Illuminating the Value of Its Fanbase (and Programming) (GlobeNewswire) +5.33%
09:01AM	Loading…
Jan-06-26 09:01AM	Comscore Launches Daily Program-Level Reporting with Deduplicated Insights on Shows and Episodes across CTV and Linear TV (GlobeNewswire)
07:00AM	Comscore Completes Recapitalization Transaction with Preferred Stockholders Following Approval from Common Stockholders (GlobeNewswire)
Dec-28-25 05:30AM	Theres No Happy Ending for Movie Theaters, No Matter Who Wins Warner (The Wall Street Journal)
Dec-26-25 10:26AM	Next year's box office will be the biggest since the pandemic, says Comscore's Paul Dergarabedian (CNBC TV)
Dec-15-25 10:47AM	Zootopia 2 Clears $1 Billion Globally as U.S. Box Office Hits $75.1 Million (GuruFocus.com) +8.23%
09:05AM	Comscore Expands Cross-Platform Campaign Measurement to Include Audio and Social (GlobeNewswire)
Dec-11-25 03:32PM	Every Media Company Has To Embrace AI: Dergarabedian (Bloomberg)
Dec-08-25 04:09PM	Comscore Releases 2025 AI Intelligence Report: Establishing New Benchmarks for Generative AI Adoption and Influence (GlobeNewswire)
Dec-05-25 12:01AM	Netflix Is Buying Warner Bros. So Who Changes Whom? (The Daily Upside) -5.23%
12:01AM	If Netflix Buys Warner, Who Changes Whom? (The Daily Upside)
07:57AM	Loading…
Nov-28-25 07:57AM	Setup for really solid Thanksgiving holiday box office, says Comscore's Paul Dergarabedian (CNBC TV)
Nov-23-25 03:00PM	Universals Wicked: For Good Defies Gravity In Box Office Debut (Barrons.com)
Nov-05-25 08:00AM	Comscore and Polaris I/O Partner to Automate Audience Insights in MarketView for Faster Media Sale (GlobeNewswire) -8.78%
12:09AM	comScore Inc (SCOR) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Nov-04-25 05:14PM	ComScore: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Comscore Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-03-25 08:14AM	Earnings To Watch: comScore Inc (SCOR) Reports Q3 2025 Result (GuruFocus.com)
Oct-29-25 09:00AM	Comscore's 2025 State of Streaming Report Reveals Surging Growth of Both Ad-Supported Platforms and FAST Channels (GlobeNewswire)
Oct-21-25 08:00AM	Comscore to Announce Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-08-25 08:00AM	Comscore and TiVo Announce Partnership to Power Cross-Platform Audience Measurement Across Linear and Streaming (GlobeNewswire)
Sep-29-25 08:08AM	Comscore Cuts Dividends, Reshapes Board (Benzinga) +46.24%
06:00AM	Comscore Announces Pivotal Recapitalization Transaction with Preferred Stockholders (GlobeNewswire)
Sep-28-25 04:57PM	Warner Bros. Notches Another Box Office Win. One Battle After Another Tops Sales. (Barrons.com)
Sep-18-25 10:30AM	From scrappy challenger to IPO: Chris Britt brings Chimes playbook to TechCrunch Disrupt 2025 (TechCrunch) +6.23%
Sep-16-25 08:30AM	Comscore Unveils The Scoreboard: An Interactive Destination Surfacing Consumer Behaviors and Trends Across Multiple Platforms (GlobeNewswire) -7.05%
02:32PM	Loading…
Sep-12-25 02:32PM	Paramount-Warner Deal Could Spark Media M&A Frenzy (Bloomberg) +5.75%
Sep-03-25 12:00PM	AI Assistants Go Mobile: Comscore Reports Surge in Mobile AI Tool Usage (GlobeNewswire)
08:30AM	Comscore Debuts AI-Powered Data Partner Network to Transform Audience Insights Data at Scale (GlobeNewswire)
Aug-14-25 06:47PM	FOX NEWS DIGITAL LEADS ALL NEWS AND BROADCAST BRANDS WITH UNIQUE VISITORS IN JULY 2025 (PR Newswire) -6.52%
Aug-08-25 08:00AM	Gray Media Agrees to Purchase Television Stations in Ten Markets from Byron Allens Allen Media Group (GlobeNewswire)
Aug-06-25 03:32AM	comScore Inc (SCOR) Q2 2025 Earnings Call Highlights: Strong Cross-Platform Growth Amid ... (GuruFocus.com) +22.59%
Aug-05-25 05:15PM	comScore (SCOR) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.35%
04:08PM	ComScore: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Comscore Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-04-25 10:12AM	Earnings To Watch: comScore Inc (SCOR) Reports Q2 2025 Result (GuruFocus.com) -5.80%
Jul-31-25 08:45AM	APi (APG) Beats Q2 Earnings and Revenue Estimates (Zacks)
Jul-27-25 02:26PM	Disneys Fantastic Four Rockets to $118 Million Debut (Barrons.com)
Jul-22-25 08:30AM	Comscore to Announce Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-18-25 11:49AM	OUTKICK DELIVERS STRONG 2ND QUARTER INCREASES IN 2025 (PR Newswire) +7.21%
Jul-17-25 06:30PM	FOX NEWS DIGITAL MARKS ITS BEST QUARTER IN HISTORY WITH TOTAL DIGITAL UNIQUE MULTIPLATFORM VISITORS (PR Newswire)
08:00AM	GameSquare Completes $70 Million Public Offering (PR Newswire)
Jul-15-25 11:00PM	CJ 4DPLEX Outpaces Domestic Box Office Growth with Record-Breaking First Half of 2025 (PR Newswire) -6.16%
08:44AM	Comscore Partners with HyphaMetrics to Launch Advanced Person-Level Audience Measurement and CTV Program-Level Reporting (GlobeNewswire)
Jul-14-25 08:48AM	Comscore, iSpot, VideoAmp pass currency audit ahead of broadcast season (Marketing Dive)
Jul-13-25 03:25PM	Superman Leads Blockbuster Summer Box Office Weekend (Barrons.com)
Jul-10-25 08:15AM	Comscore Achieves Full JIC Certification for National TV Measurement Including Persons-Based Data (GlobeNewswire) +7.72%
08:00AM	U.S. Joint Industry Committee Completes Audit of Certified Currencies to Validate Transactability of New Data for the Upcoming Broadcast Season (PR Newswire)
Jun-30-25 01:22AM	Apple's 'F1: The Movie' roars to top of US, Canada box office (Reuters Videos)
Jun-18-25 09:52AM	FOX NEWS DIGITAL CONTINUES TO DOMINATE NEWS BRANDS DURING MAY DELIVERING SECOND HIGHEST MONTH WITH TOTAL DIGITAL MULTIPLATFORM UNIQUE VISITORS IN NETWORK HISTORY (PR Newswire)
Jun-10-25 08:15AM	Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform (GlobeNewswire)
Jun-04-25 08:15AM	Comscore and ShowSeeker Partner to Bring Person-Level Data to Pilot Platform, Advancing Local TV Campaign Precision (GlobeNewswire)
May-29-25 08:15AM	Comscore Adds Consumer AI Tool Usage Data to Its Industry-Leading Suite of Reporting (GlobeNewswire)
May-28-25 08:15AM	Yahoo DSP Onboards Comscore's AI-Powered ID-Free Audiences for Efficient and Privacy-Centric Campaign Activation (GlobeNewswire)
May-27-25 10:31AM	AMC Announces Record-Breaking Memorial Day Numbers, Thanks to 'Lilo & Stitch' (Investopedia)
May-07-25 06:02AM	Q1 2025 Comscore Inc Earnings Call (Thomson Reuters StreetEvents)
03:23AM	comScore Inc (SCOR) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com)
May-06-25 05:50PM	ComScore (SCOR) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Comscore Reports First Quarter 2025 Results (GlobeNewswire)
May-05-25 05:55PM	Crawford & Company B (CRD.B) Surpasses Q1 Earnings Estimates (Zacks)
10:26AM	comScore Inc (SCOR) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:30AM	Comscore Launches Certified Deal IDs in Magnite's SSP, Bringing Trusted Content Rankings to Programmatic Buying (GlobeNewswire)
Apr-23-25 08:15AM	Healthcare Services (HCSG) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	Comscore To Announce First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 08:30AM	Comscore Secures Multi-Season Agreement with The Summit League (GlobeNewswire)
Apr-08-25 08:30AM	Comscore Awarded Media Rating Council (MRC) Accreditation for Demographic Households With Metrics in National and Local TV Measurement, Reinforcing Leadership in Big Data TV Ratings (GlobeNewswire)
Apr-03-25 04:05PM	AerSale Announces Appointment of Two New Board Members and Upcoming Board Transitions (Business Wire) -9.09% -8.91%
Mar-05-25 08:14AM	Q4 2024 Comscore Inc Earnings Call (Thomson Reuters StreetEvents) +21.54%
02:10AM	comScore Inc (SCOR) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... (GuruFocus.com)
Mar-04-25 05:05PM	ComScore (SCOR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:24PM	ComScore: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Comscore Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Mar-03-25 07:27AM	comScore Inc (SCOR) Q4 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Feb-21-25 04:15PM	Comscore to Announce Fourth Quarter 2024 Financial Results (GlobeNewswire) -6.33%
Feb-20-25 08:30AM	Comscore Expands YouTube CTV Viewership Measurement to International Markets (GlobeNewswire)
Jan-24-25 04:57PM	Nielsen to End Panel-Only Ratings That Have Measured TV for Decades (The Wall Street Journal) -8.33%
Jan-22-25 08:00AM	Comscore Appoints Industry Change-Maker Frank Friedman to Lead Next Era of Measurement Transformation (GlobeNewswire)
Jan-21-25 08:30AM	Proximic by Comscore Releases 2025 State of Programmatic Report (GlobeNewswire)
Jan-16-25 09:39AM	Comscore Announces Unified Content Measurement (GlobeNewswire)
Jan-14-25 08:30AM	Comscore Expands Local Currency Partnership with Coastal Television's Media Group to Deliver Advanced TV Measurement Across 12 Markets (GlobeNewswire)
Jan-02-25 09:00AM	Comscore Appoints New Chief Marketing Officer (GlobeNewswire) +14.90%
Dec-20-24 08:00AM	Comscore Expands Long-Term Local Currency Partnership with Gray Media to Include Advanced Audience Measurement in Multi-Year Agreement (GlobeNewswire)
Dec-05-24 08:00AM	FreeWheel Launches First of its Kind Contextual Marketplace, Informed by Research from the FreeWheel Viewer Experience Labs New Report, which Found Viewers are 2X More Engaged When Ads are Relevant (Business Wire)
Dec-01-24 01:10PM	Moana 2 Lifts Box Office to Thanksgiving Record With $221 Million Haul (The Wall Street Journal)
Nov-20-24 08:30AM	Comscore Awarded US Patent For Person-Level TV Audience Measurement, Transforming Precision in Media Targeting (GlobeNewswire)
Nov-13-24 02:21AM	comScore Inc (SCOR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com) +41.09%
Nov-12-24 05:15PM	ComScore (SCOR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Comscore Reports Third Quarter 2024 Results (GlobeNewswire)
Nov-11-24 07:27AM	comScore Inc (SCOR) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.03%
Oct-25-24 08:30AM	Comscore to announce third quarter 2024 financial results (GlobeNewswire)
Sep-11-24 08:30AM	Proximic by Comscore Releases Inaugural Report on the State of Privacy in Advertising for 2024, Highlighting Industry Shifts and Challenges (GlobeNewswire)
Sep-06-24 07:21AM	What Brings Significant Value Appreciation For comScore (SCOR)? (Insider Monkey) -5.73%
Sep-05-24 08:00AM	Statara Solutions Cements Groundbreaking Partnership with Proximic by Comscore to Enhance the Statara Media Platform (PR Newswire) +5.61%
Aug-26-24 08:30AM	Comscore and FreeWheel Forge Next-Gen Partnership, Further Enhancing Privacy-Resilient CTV and Contextual Advertising (GlobeNewswire)
Aug-21-24 08:59AM	Comscore Campaign Ratings Now Integrated Into Basis Technologies for Comprehensive Cross-Channel Incremental Reach Measurement (GlobeNewswire)
Aug-14-24 08:00AM	Horizon Media Taps Comscore as Preferred Contextual Intelligence Provider to Tackle Signal Loss and Privacy Challenges (GlobeNewswire)

comScore, Inc. is a global information and analytics company, which engages in the measurement of audiences, consumer behavior, and advertising across media platforms. The company was founded by Magid M. Abraham and Gian Mark Fulgoni in August 1999 and is headquartered in Reston, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FISHER ITZHAK	Director	Dec 29 '25	Option Exercise	0.00	10,000	0	43,007	Dec 31 05:25 PM
Banerjee Nana	Director	Dec 29 '25	Option Exercise	0.00	10,000	0	35,624	Dec 31 05:24 PM
Gillin Leslie	Director	Dec 29 '25	Option Exercise	0.00	10,000	0	33,354	Dec 31 05:23 PM
Patterson Martin Edward	Director	Dec 29 '25	Option Exercise	0.00	10,000	0	38,682	Dec 31 05:21 PM
LIVEK WILLIAM PAUL	Director	Nov 14 '25	Sale	6.55	9,900	64,845	187,473	Nov 17 05:40 PM
LIVEK WILLIAM PAUL	Director	Nov 12 '25	Sale	6.85	2,002	13,723	197,373	Nov 14 04:08 PM
LIVEK WILLIAM PAUL	Director	Nov 11 '25	Sale	7.12	3,735	26,589	199,375	Nov 12 05:14 PM
LIVEK WILLIAM PAUL	Director	Nov 10 '25	Sale	7.57	2,206	16,699	203,110	Nov 12 05:14 PM
LIVEK WILLIAM PAUL	Director	Nov 10 '25	Proposed Sale	7.86	20,000	157,200		Nov 10 10:48 AM
Bagdasarian Stephen	Chief Commercial Officer	Sep 26 '25	Option Exercise	0.00	1,250	0	6,431	Sep 30 06:02 PM
Wendling Brian J	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	32,507	Jun 20 05:03 PM
McLaughlin Matthew F.	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	135,739	Jun 20 05:03 PM
Patterson Martin Edward	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	28,682	Jun 20 05:03 PM
LIVEK WILLIAM PAUL	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	205,316	Jun 20 05:02 PM
Gillin Leslie	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	23,354	Jun 20 05:02 PM
FISHER ITZHAK	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	33,007	Jun 20 05:01 PM
Banerjee Nana	Director	Jun 17 '25	Option Exercise	0.00	10,739	0	25,624	Jun 20 05:01 PM
CHARTER COMMUNICATIONS, INC. /	10% Owner	Jun 17 '25	Option Exercise	0.00	21,478	0	49,789	Jun 20 04:12 PM
Bagdasarian Stephen	Chief Commercial Officer	Jun 06 '25	Option Exercise	0.00	2,475	0	5,907	Jun 10 04:08 PM

FOLD

Amicus Therapeutics Inc

SCOR

Comscore Inc

Upgrade your FINVIZ experience